|
Volumn 18, Issue 9, 2008, Pages 2886-2890
|
Novel echinocandin antifungals. Part 2: Optimization of the side chain of the natural product FR901379. Discovery of micafungin
|
Author keywords
Antifungal; Aspergillus fumigatus; Candida albicans; Echinocandin; FK463; FR13153; FR901379; Isoxazole; Micafungin; Natural product
|
Indexed keywords
ECHINOCANDIN;
FR 131535;
FR 901379;
MICAFUNGIN;
NATURAL PRODUCT;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANTIFUNGAL ACTIVITY;
AREA UNDER THE CURVE;
ARTICLE;
ASPERGILLOSIS;
ASPERGILLUS FUMIGATUS;
CANDIDA ALBICANS;
CANDIDIASIS;
CONTROLLED STUDY;
DRUG DESIGN;
DRUG EFFICACY;
DRUG ELIMINATION;
DRUG HALF LIFE;
DRUG POTENCY;
HEMOLYSIS;
IC 50;
LIPOPHILICITY;
MINIMUM INHIBITORY CONCENTRATION;
MOUSE;
NONHUMAN;
TREATMENT OUTCOME;
ANTIFUNGAL AGENTS;
ASPERGILLUS FUMIGATUS;
BIOLOGICAL PRODUCTS;
CANDIDA ALBICANS;
ECHINOCANDINS;
LIPOPROTEINS;
MICROBIAL SENSITIVITY TESTS;
MODELS, CHEMICAL;
PEPTIDES, CYCLIC;
STRUCTURE-ACTIVITY RELATIONSHIP;
ASPERGILLUS FUMIGATUS;
CANDIDA ALBICANS;
|
EID: 42949150245
PISSN: 0960894X
EISSN: None
Source Type: Journal
DOI: 10.1016/j.bmcl.2008.03.093 Document Type: Article |
Times cited : (29)
|
References (14)
|